Literature DB >> 12401802

Structure and dynamics of thioguanine-modified duplex DNA.

Lilla Somerville1, Eugene Y Krynetski, Natalia F Krynetskaia, Richard D Beger, Weixing Zhang, Craig A Marhefka, William E Evans, Richard W Kriwacki.   

Abstract

Mercaptopurine and thioguanine, two of the most widely used antileukemic agents, exert their cytotoxic, therapeutic effects by being incorporated into DNA as deoxy-6-thioguanosine. However, the molecular mechanism(s) by which incorporation of these thiopurines into DNA translates into cytotoxicity is unknown. The solution structure of thioguanine-modified duplex DNA presented here shows that the effects of the modification on DNA structure were subtle and localized to the modified base pair. Specifically, thioguanine existed in the keto form, formed weakened Watson-Crick hydrogen bonds with cytosine and caused a modest approximately 10 degrees opening of the modified base pair toward the major groove. In contrast, thioguanine significantly altered base pair dynamics, causing an approximately 80-fold decrease in the base pair lifetime with cytosine compared with normal guanine. This perturbation was consistent with the approximately 6 degrees C decrease in DNA melting temperature of the modified oligonucleotide, the 1.13 ppm upfield shift of the thioguanine imino proton resonance, and the large increase in the exchange rate of the thioguanine imino proton with water. Our studies provide new mechanistic insight into the effects of thioguanine incorporation into DNA at the level of DNA structure and dynamics, provide explanations for the effects of thioguanine incorporation on the activity of DNA-processing enzymes, and provide a molecular basis for the specific recognition of thioguanine-substituted sites by proteins. These combined effects likely cooperate to produce the cellular responses that underlie the therapeutic effects of thiopurines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401802     DOI: 10.1074/jbc.M204243200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Structural effect of the anticancer agent 6-thioguanine on duplex DNA.

Authors:  Jen Bohon; Carlos R de los Santos
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

Review 2.  Use of thiopurines in inflammatory bowel disease: Safety issues.

Authors:  Anastasia Konidari; Wael El Matary
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

3.  TPMT*26 (208F-->L), a novel mutation detected in a Chinese.

Authors:  Shirley Kow Yin Kham; Chin Kok Soh; Derrick Chen Wee Aw; Allen Eng Juh Yeoh
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

4.  Enhanced base pairing and replication efficiency of thiothymidines, expanded-size variants of thymidine.

Authors:  Herman O Sintim; Eric T Kool
Journal:  J Am Chem Soc       Date:  2006-01-18       Impact factor: 15.419

5.  Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo.

Authors:  Yihong Hu; Bo Wu; Allen Zillmer; Peijuan Lu; Ehsan Benrashid; Mingxing Wang; Timothy Doran; Mona Shaban; Xiaohua Wu; Qi Long Lu
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

6.  High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

Authors:  Natalia Krynetskaia; Hongbo Xie; Slobodan Vucetic; Zoran Obradovic; Evgeny Krynetskiy
Journal:  Mol Pharmacol       Date:  2007-10-19       Impact factor: 4.436

7.  Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.

Authors:  G Stocco; M H Cheok; K R Crews; T Dervieux; D French; D Pei; W Yang; C Cheng; C-H Pui; M V Relling; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

8.  Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.

Authors:  Natalia F Krynetskaia; Manali S Phadke; Sachin H Jadhav; Evgeny Y Krynetskiy
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

9.  Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore.

Authors:  Shirley Kow Yin Kham; Chin Kok Soh; Te Chih Liu; Yiong Huak Chan; Hany Ariffin; Poh Lin Tan; Allen Eng Juh Yeoh
Journal:  Eur J Clin Pharmacol       Date:  2008-01-11       Impact factor: 2.953

Review 10.  Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.

Authors:  Jaehyun Kim; Linda A Feagins
Journal:  Dig Dis Sci       Date:  2019-11-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.